Sign in

CIK 0001962011

  • Emerging growth company

Kairos Pharma, LTD.

Sign in to watch
Ticker
KAPA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
462993314
Phone
+1 818-404-5541
Business address
2355 WESTWOOD BLVD. #139, LOS ANGELES, CA, 90064
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-10-08 Samuelson Doug Chief Financial Officer Grant or award +152,672 293,039
2024-11-22 Samuelson Doug Chief Financial Officer Purchase +2,500 $1.50 $4K 60,796

Page 1 of 1 · 2 trades